These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28649428)

  • 1. The UK ME/CFS Biobank for biomedical research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis.
    Lacerda EM; Bowman EW; Cliff JM; Kingdon CC; King EC; Lee JS; Clark TG; Dockrell HM; Riley EM; Curran H; Nacul L
    Open J Bioresour; 2017; 4():. PubMed ID: 28649428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The UK ME/CFS Biobank: A Disease-Specific Biobank for Advancing Clinical Research Into Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Lacerda EM; Mudie K; Kingdon CC; Butterworth JD; O'Boyle S; Nacul L
    Front Neurol; 2018; 9():1026. PubMed ID: 30564186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Cliff JM; King EC; Lee JS; Sepúlveda N; Wolf AS; Kingdon C; Bowman E; Dockrell HM; Nacul L; Lacerda E; Riley EM
    Front Immunol; 2019; 10():796. PubMed ID: 31057538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hope, disappointment and perseverance: Reflections of people with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis participating in biomedical research. A qualitative focus group study.
    Lacerda EM; McDermott C; Kingdon CC; Butterworth J; Cliff JM; Nacul L
    Health Expect; 2019 Jun; 22(3):373-384. PubMed ID: 30632248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls.
    Giloteaux L; Li J; Hornig M; Lipkin WI; Ruppert D; Hanson MR
    J Transl Med; 2023 May; 21(1):322. PubMed ID: 37179299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of Clinical Pathology Abnormalities in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) from an Analytic Cross-Sectional Study.
    Nacul L; de Barros B; Kingdon CC; Cliff JM; Clark TG; Mudie K; Dockrell HM; Lacerda EM
    Diagnostics (Basel); 2019 Apr; 9(2):. PubMed ID: 30974900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction.
    Sweetman E; Kleffmann T; Edgar C; de Lange M; Vallings R; Tate W
    J Transl Med; 2020 Sep; 18(1):365. PubMed ID: 32972442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association analysis between symptomology and herpesvirus IgG antibody concentrations in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and multiple sclerosis.
    Domingues TD; Malato J; Grabowska AD; Lee JS; Ameijeiras-Alonso J; Biecek P; Graça L; Mouriño H; Scheibenbogen C; Westermeier F; Nacul L; Cliff JM; Lacerda E; Sepúlveda N
    Heliyon; 2023 Jul; 9(7):e18250. PubMed ID: 37519635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing a Blood Cell-Based Diagnostic Test for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Using Peripheral Blood Mononuclear Cells.
    Xu J; Lodge T; Kingdon C; Strong JWL; Maclennan J; Lacerda E; Kujawski S; Zalewski P; Huang WE; Morten KJ
    Adv Sci (Weinh); 2023 Oct; 10(30):e2302146. PubMed ID: 37653608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery.
    Gómez-Mora E; Carrillo J; Urrea V; Rigau J; Alegre J; Cabrera C; Oltra E; Castro-Marrero J; Blanco J
    Front Immunol; 2020; 11():582330. PubMed ID: 33329554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DecodeME: community recruitment for a large genetics study of myalgic encephalomyelitis / chronic fatigue syndrome.
    Devereux-Cooke A; Leary S; McGrath SJ; Northwood E; Redshaw A; Shepherd C; Stacey P; Tripp C; Wilson J; Mar M; Boobyer D; Bromiley S; Chowdhury S; Dransfield C; Almas M; Almelid Ø; Buchanan D; Garcia D; Ireland J; Kerr SM; Lewis I; McDowall E; Migdal M; Murray P; Perry D; Ponting CP; Vitart V; Wolfe JC
    BMC Neurol; 2022 Jul; 22(1):269. PubMed ID: 35854226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of circulating biomarkers with illness severity measures differentiates myalgic encephalomyelitis/chronic fatigue syndrome and post-COVID-19 condition: a prospective pilot cohort study.
    Domingo JC; Battistini F; Cordobilla B; Zaragozá MC; Sanmartin-Sentañes R; Alegre-Martin J; Cambras T; Castro-Marrero J
    J Transl Med; 2024 Apr; 22(1):343. PubMed ID: 38600563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.
    Cabanas H; Muraki K; Balinas C; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
    Mol Med; 2019 Apr; 25(1):14. PubMed ID: 31014226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci.
    Hajdarevic R; Lande A; Mehlsen J; Rydland A; Sosa DD; Strand EB; Mella O; Pociot F; Fluge Ø; Lie BA; Viken MK
    Brain Behav Immun; 2022 May; 102():362-369. PubMed ID: 35318112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D status in chronic fatigue syndrome/myalgic encephalomyelitis: a cohort study from the North-West of England.
    Earl KE; Sakellariou GK; Sinclair M; Fenech M; Croden F; Owens DJ; Tang J; Miller A; Lawton C; Dye L; Close GL; Fraser WD; McArdle A; Beadsworth MBJ
    BMJ Open; 2017 Nov; 7(11):e015296. PubMed ID: 29118054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Status and Well-Being in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Compared with People with Multiple Sclerosis and Healthy Controls.
    Kingdon CC; Bowman EW; Curran H; Nacul L; Lacerda EM
    Pharmacoecon Open; 2018 Dec; 2(4):381-392. PubMed ID: 29536371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.
    Lidbury BA; Kita B; Lewis DP; Hayward S; Ludlow H; Hedger MP; de Kretser DM
    J Transl Med; 2017 Mar; 15(1):60. PubMed ID: 28302133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unique circular RNA expression pattern in the peripheral blood of myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Cheng Y; Xu SM; Takenaka K; Lindner G; Curry-Hyde A; Janitz M
    Gene; 2023 Aug; 877():147568. PubMed ID: 37328077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of multiple sclerosis with chronic fatigue syndrome, restless legs syndrome, and various sleep disorders, along with the recent updates.
    Prajjwal P; Kalluru PKR; Marsool MD; Inban P; Gadam S; Al-Ezzi SMS; Marsool AD; Al-Ibraheem AMT; Al-Tuaama AZH; Amir O; Arunachalam SP
    Ann Med Surg (Lond); 2023 Jun; 85(6):2821-2832. PubMed ID: 37363482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.